Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Nephrology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Interview: David Wheeler
6
Mins
July 2024
When I was a junior doctor, I was exposed to a number of different chronic diseases. However, kidney disease fascinated me the most…
Read more
6
Mins
24th July 2024
Interview: David Wheeler
When I was a junior doctor, I was exposed to a number of different chronic diseases. However, kidney disease fascinated me the most…
5
Mins
4th July 2024
Immune Complex-mediated MPGN Secondary to Primary Biliary Cholangitis
Immune complex-mediated membranoproliferative glomerulonephritis (iMPGN) can develop in association with autoimmune diseases such as…
8
Mins
4th July 2024
Characteristics, Humanistic Burden, and Kidney Outcomes in Immunoglobulin A Nephropathy
IgAN is an immune-complex mediated glomerular disease with an incidence rate of 0.03−10.5/100,000 persons/year…
12
Mins
4th July 2024
Challenges in Renal Replacement Therapy in Resource-limited Settings
Chronic kidney disease (CKD) continues to be a global public health problem. Globally, the prevalence of CKD is approximately 8–16% in the…
12
Mins
4th July 2024
End-Stage Renal Disease and Neurological Connection
Due to the incapacitating nature of end-stage renal disease, people on dialysis frequently acquire undetected psychopathological disorders.
2
Mins
4th April 2024
Chronic Active Antibody-Mediated Rejection in Renal Transplant Recipients
In 2022, over 92,000 kidney transplants were performed globally.1 With advancements in transplant science, 1-year graft survival rates…
7
Mins
14th March 2024
Sparsentan for treatment of immunoglobulin A nephropathy: Latest study results
In patients with immunoglobulin A nephropathy, use of the endothelin 1 Type A/Ang II subtype 1 receptor antagonist sparsentan can decrease proteinuria and preserve kidney function
8
Mins
14th March 2024
Renal Replacement Therapy
End-stage liver disease (ESLD) represents a non-reversible, advanced stage of cirrhosis, where the hepatic architecture is distorted and…
Loading posts...
1
2
3
…
19
Next »